The global Metabolic Testing Market is estimated to be valued at Us$ 641.62 Mn in 2023 and is expected to exhibit a CAGR Of 7.6% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Metabolic testing products include metabolic carts, respiratory gas analyzers, ECG and body composition monitors. These products are used for measuring oxygen consumption, carbon dioxide production, lung function, energy expenditure and other parameters associated with metabolism. Increasing prevalence of lifestyle diseases such as diabetes and obesity has fueled the need for metabolic testing tools for diagnosis and monitoring.
Market key trends:
Wearable technology is emerging as one the key trends in the metabolic testing market. Various wearable devices are being launched that can monitor metabolic parameters continuously and seamlessly. For instance, fitness bands are integrated with heart rate monitors, pulse oximeters and global positioning system (GPS) to provide metrics on calorie burn, heart rate variability and other fitness indicators. Some smart watches are equipped with ECG monitors and have received FDA clearance for detecting abnormal heart rhythms. Further, clothing integrated with sensors is being developed that can track parameters like breathing rate, steps and energy expenditure. This is expected to drive wider adoption of metabolic testing devices.
Segment Analysis
The global metabolic testing market is segmented into product type, technology, end-user and region. Based on product type, the metabolic testing market is segmented into portable metabolic systems and laboratory-based metabolic testing systems. The portable metabolic systems segment dominated the global metabolic testing market in 2022 and is expected to continue its dominance over the forecast period. Portable metabolic systems are highly preferred by end users owing to their ease of use and portability.
Key Takeaways
The Global Metabolic Testing Market Demand is expected to reach US$ 1,007.56 Mn by 2030, expanding at a CAGR of 7.6% over the forecast period. Increasing prevalence of obesity and diabetes is expected to drive the market during the forecast period.
Regional analysis
Regionally, North America dominated the global metabolic testing market in 2022 and is expected to continue its domination over the forecast period. This is attributed to growing prevalence of chronic metabolic diseases along with supportive reimbursement policies in the region. Asia Pacific is expected to witness fastest growth over the forecast period attributed to improving healthcare infrastructure and rising medical tourism in the region.
Key players
Key players operating in the metabolic testing market are COSMED srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., Iworx Systems, GE Healthcare, Hologic, Inc, Geratherm Medical AG, and Parvo Medics. Among these, COSMED srl and Vyaire Medical, Inc. hold a significant share in the global market owing to their diverse product portfolio and strong geographical presence.
During a controlled environment, the testing will determine the amount of calories (food energy) and volume of oxygen consumption and output.
There are three major factors that influence metabolic test results: physical activity, sleep, and food intake, and metabolism.
A measurement of substrate utilization, known as substrate cycling, is used in conjunction with body composition analysis to assess changes in the energy and macronutrient balance and to identify potential dietary recommendations.
When multiple measurements are combined, metabolic testing can provide detailed metabolic information for an individual.Based on measurements of biochemical and metabolic markers, test results are interpreted and compared to specific target values to determine whether the metabolic state of an individual is in a suitable state for optimal health.
This test is often used to detect excessive fat accumulation or hypoxemia and to determine the effects of nutritional status on body weight.
In addition, the test is frequently employed to monitor the progression of chronic diseases, such as diabetes.An exercise session triggers physiological responses in the body, resulting in increased heart rate, enhanced oxygen consumption, and production of neurotransmitters like dopamine and epinephrine.
